Article Information
History
- September 5, 2021.
Article Versions
- Version 1 (July 27, 2021 - 07:37).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joan-Ramon Laporte, M.D.1,*,
- Ermengol Coma, M.D.2,
- Francesc Fina, M.D.2,
- Luís García-Eroles, M.D.3,
- Xavier Vidal, M.D.4 and
- Manuel Medina, M.D.2
- 1Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Fundació Institut Català de Farmacologia, HU Vall d’Hebron, P Vall d’Hebron 129-139, 08035 Barcelona
- 2SISAP. Sistema d’Informació dels Serveis d’Atenció Primària, Direcció Assistencial d’Atenció Primària i a la Comunitat, Institut Català de la Salut, Departament de Salut, Generalitat de Catalunya, Gran Via de les Corts Catalanes, 587, 08007 Barcelona
- 3Àrea de Sistemes d’Informació, Servei Català de la Salut, Departament de Salut, Generalitat de Catalunya, Travessera de les Corts, 131-159, 08028 Barcelona
- 4Servei de Farmacologia Clínica, Hospital Universitari Vall d’Hebron, Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, HU Vall d’Hebron, P Vall d’Hebron 129-139, 08035 Barcelona
- ↵*Corresponding author:
Joan-Ramon Laporte jrl{at}icf.uab.cat Phone: 0034-669747107
Contributions All authors contributed to the study design. LGE and MM contributed to the study execution (data holders). LGE, FF, and EC verified the underlying data. FF, EC, JRL, and XV carried out the data analysis. JRL wrote the first draft of the manuscript, which was subsequently revised for by the remaining authors. All authors approved the final version of the manuscript prior to submission and had final responsability for the decision to submit it for publication. LGE and MM are guarantors. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
Posted September 05, 2021.
Vaccines against Covid-19, venous thromboembolism, and thrombocytopenia. A population-based retrospective cohort study
